Feature | Cardiovascular Education | May 02, 2019| Judy Haluka, RCIS, EMT

The Basics of the Pediatric Tachycardia for Pediatric Advanced Life Support

A quick guide to PALS pediatric tachycardia guidelines

This is the AHA pediatric tachycardia PALS algorithm flow sheet.

This is the AHA pediatric tachycardia PALS algorithm flow sheet. Download a copy of this at www.acls.net/images/algo-pals-Tachycardia.pdf.

The treatment of all patients in distress with significant symptoms begins with the basics, and pediatric tachycardia is no different. Here is the outline of the American Heart Association (AHA) Pediatric Advanced Life Support (PALS) guidelines.

First Steps:

   • Oxygen if indicated by pulse oximetry less than 95% or shortness of breath.
   • Maintain airway.
   • Place the patient on the cardiac monitor.
   • Monitor vital signs, including oximetry.
   • IV or IO access.
   • 12 Lead ECG to assist with diagnosis if the condition of the patient permits (do not delay emergent treatment).
   • The treatment of tachycardia is based on the type of tachycardia.  

 

Identify The Type of Tachycardia

There are three possible types. Narrow complex tachycardia, which is further divided into sinus tachycardia and supraventricular tachycardia, and wide complex tachycardia, which might be a possible ventricular tachycardia.

Narrow complex tachycardia must have a QRS duration less than 0.1 seconds.

 

Sinus Tachycardia:

   • Diagnosis is often based upon history.  This patient will have a history consistent with a known cause that requires compensation.  For example, dehydration, pain, hypovolemia.
   • P waves are normal, rhythm is regular and rate is usually less than 220  per minute in infants and 180 in children.

TREATMENT: Find and treat the underlying cause. For example, in dehydration replace fluid; treat pain, etc.

 

Supraventricular Tachycardia:

   • History is vague.
   • P waves are absent or abnormal looking, heart rate is usually greater than 220 in infants and greater than 180 in children.

Treatment: If IV or IO is available, give adenosine 0.1 mg/kg rapid bolus (maximum of 6 mg)  This can be repeated with a second dose of 0.2 mg/kg rapid bolus (maximum of 12 mg).
 
If adenosine is unsuccessful, or IV/IO access is not available synchronized cardioversion is indicated. 
   • Start at 0.5-1.0 joules/kg — if not effective increase to 2 joules/kg.
   • Sedate if needed, but do not delay treatment.

 

Wide Complex Tachycardia (QRS >0.09 secs) — Probable Ventricular Tachycardia:

Always begin with the basics. 
   • If the child is hypotensive, has acute altered level of consciousness, or signs of shock, Immediate synchronized cardioversion is indicated.
     - 0.5 joules/kg
     - 2 joules/kg
• If no hypotension, altered level, or signs of shock, and the rhythm is regular with monomorphic (all QRSs look alike) consider using adenosine.
     - Adenosine 0.1 mg/kg rapid IV bolus maximum of 6 mg.
     - Adenosine 0.2 mg/kg rapid IV bolus maximum of 12 mg.
• If no hypotension, altered level or signs of shock consult an expert (cardiology or electrophysiology) who will consider:
     - Amiodarone 5 mg/kg IV/IO over 20-60 minutes, or
     - Procainamide IO/IV 15 mg over 30-60 minutes.
     - However, these should not be administered together.

The information in this article provided by from the ACLS Training Center is current with respect to 2015 AHA Guidelines for CPR and ECC. These guidelines are current until their expected update in October 2020.

 

Download a PDF version the pediatric tachycardia algorithm.

 

Editor's note: The author Judy Haluka, RCIS, EMT, started her career at a tertiary hospital in the cardiac catheterization laboratory following receipt of her bachelor’s in biology/cardiac sciences in the early 1980’s. She is credentialed as a registered cardiovascular invasive specialist through Cardiovascular Credentialing International. She is further credentialed as an emergency medical technician – paramedic through the Pennsylvania Department of Health.

Related Content

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

News | Cardiac Diagnostics | July 29, 2021
July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation Ambula
The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

News | Cardiac Diagnostics | July 01, 2021
July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc.
Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Detecting heart disease with OCT imaging of the eye.Getty Images

Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Getty Images
 

News | Cardiac Diagnostics | March 08, 2021
March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potent
Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia.

Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG strip on a smartphone. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia. 

News | Cardiac Diagnostics | March 03, 2021
March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management s
A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images Health disparities in cardiovascular disease.

A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images

News | Cardiac Diagnostics | February 02, 2021
February 2, 2021 — A new study has found in the U.S.
A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

News | Cardiac Diagnostics | January 06, 2021
January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects
The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia. 

News | Cardiac Diagnostics | October 06, 2020
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc.
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en